Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Medicine
{PDF} Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary Steve Olson and Adam C. Berger; Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine
$9.99
Related products
-
Engineering
[PDF] Examining Core Elements of International Research Collaboration: Summary of a Workshop Planning Committee for the Workshop on Examining Core Elements of International Collaboration, Government-University-Industry Research Roundtable, Policy and Global Affairs, National Academy of Sciences, National Academy of Engineering, Institute of Medicine, National Academies
$19.99 Order now -
Engineering
[PDF] Observations on the President’s Fiscal Year 2002 Federal Science and Technology Budget Committee on the Federal Science and Technology Budget, Engineering, and Public Policy Committee on Science, National Academy of Sciences, National Academy of Engineering, Institute of Medicine
$19.99 Order now
Reviews
There are no reviews yet.